Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

1.500 -0.030 (-1.97%)
Streaming Delayed Price Updated: 11:44 AM EDT, Oct 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 408,296
Open 1.510
Bid (Size) 1.490 (95)
Ask (Size) 1.500 (16)
Prev. Close 1.530
Today's Range 1.490 - 1.570
52wk Range 0.6506 - 3.800
Shares Outstanding 23,873,626
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development
Via Investor Brand Network
Topics Artificial Intelligence
3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX. 
Via MarketBeat

Performance

YTD
+94.8%
+94.8%
1 Month
+2.0%
+2.0%
3 Month
+27.1%
+27.1%
6 Month
+89.9%
+89.9%
1 Year
+80.9%
+80.9%

More News

Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Tuesday?
Via Chartmill
Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data
Via News Direct
Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data
Via AB Newswire
EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers
Via Benzinga
Top 5 Biotech Stocks With Strong Momentum
Via Benzinga
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Via Get News
Topics Intellectual Property
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
From Silo Pharma, Inc.
Via GlobeNewswire
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Via Press Release Distribution Service
Topics Intellectual Property
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Nasdaq Down 1.5%; RPM Posts Upbeat Results
Via Benzinga
Why Is Hoth Therapeutics Stock Flying Higher On Tuesday?
Via Benzinga
Dow Surges Over 100 Points; US Trade Deficit Widens In November
Via Benzinga
Topics Stocks
Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is Hoth Therapeutics, Inc. - Common Stock publicly traded?
Yes, Hoth Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Hoth Therapeutics, Inc. - Common Stock trade on?
Hoth Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Hoth Therapeutics, Inc. - Common Stock?
The ticker symbol for Hoth Therapeutics, Inc. - Common Stock is HOTH on the Nasdaq Stock Market
What is the current price of Hoth Therapeutics, Inc. - Common Stock?
The current price of Hoth Therapeutics, Inc. - Common Stock is 1.500
When was Hoth Therapeutics, Inc. - Common Stock last traded?
The last trade of Hoth Therapeutics, Inc. - Common Stock was at 10/07/25 11:44 AM ET
What is the market capitalization of Hoth Therapeutics, Inc. - Common Stock?
The market capitalization of Hoth Therapeutics, Inc. - Common Stock is 35.81M
How many shares of Hoth Therapeutics, Inc. - Common Stock are outstanding?
Hoth Therapeutics, Inc. - Common Stock has 36M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.